A logo Agilent Technologies +
Agilent Technologies
+

Agilent Technologies (A) Business News

Track Agilent Technologies in real time with a live news feed covering Agilent Technologies stock news, official press releases, company announcements, and an archive of historical Agilent Technologies news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Agilent to Participate in Jefferies Global Healthcare Conference

Business Wire

4:15 PM | Monday | May 11, 2026

news photo
Loading...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the Jefferies Global Healthcare Conference. The event is scheduled for 9:20 EDT on Wednesday, June 3, 2026, in New York City. A live audio webcast and replay of the presentation will be available through Agilent's Investor Relations website.
About Agilent Technologies Agilent Technologies, Inc. (NYSE: A) is a global lead.

Read full article redirect
4:15 PM | Monday | May 11, 2026

Agilent to Participate in Jefferies Global Healthcare Conference

Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the Jefferies Global Healthcare Conference. The event is scheduled for 9:20 EDT on Wednesday, June 3, 2026, in New York City. A live audio webcast and replay of the presentation will be available through Agilent's Investor Relations website.
About Agilent Technologies Agilent Technologies, Inc. (NYSE: A) is a global lead.

Read full article arrow
News Thumbnail
8:00 AM | Monday | May 4, 2026

Agilent Names Michael Buckner as Chief Legal Officer

Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced the appointment of Michael Buckner as chief legal officer, effective today. Buckner brings nearly three decades of experience as a senior global legal executive, with a proven track record of building and leading high-performing teams and deep expertise in complex transactions and regulatory environments. “We are thrilled to welcome Michael to the Agilent team,” said Padraig McDonnell, Agilent president an.

Read full article arrow
News Thumbnail
4:15 PM | Tuesday | Apr 28, 2026

Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27

Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) will release financial results for the second quarter of fiscal year 2026 after the stock market closes on Wednesday, May 27. The company will host a conference call to discuss the results at 1:30 p.m.
PDT the same day. To join the listen-only conference call webcast, click the link on the Events section of Agilent's Investor Relations website. A recording of the call will also be available on the website for 90 days. Abo.

Read full article arrow
News Thumbnail
8:00 AM | Tuesday | Apr 21, 2026

Axion BioSystems and Agilent Technologies Resolve Litigation

Business Wire

ATLANTA--(BUSINESS WIRE)--Axion BioSystems, Inc., a leading provider of live-cell analysis technologies, today announced that Agilent Technologies, Inc. and Axion BioSystems have fully resolved the issues in the two lawsuits between them, pending in the United States District Court for the District of Delaware, pursuant to the terms of a confidential settlement agreement. Neither party has admitted liability for the other party's claims or counterclaims or otherwise agreed to the positions asse.

Read full article arrow
News Thumbnail
8:00 AM | Wednesday | Apr 15, 2026

Agilent Showcases Cancer Research Solutions at AACR 2026

Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting on April 17–22, 2026, in San Diego, California. At the meeting, Agilent will highlight advances designed to connect discovery research, translational science, and companion diagnostics development, reflecting the growing demand f.

Read full article arrow
News Thumbnail
8:00 AM | Wednesday | Apr 1, 2026

Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader

Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading and high-content cell imaging in a single platform. Building on a decade of Cytation innovation and shaped by continuous customer feedback, the BioTek Cytation 9 helps laboratories move from samples to insights faster, supporting workflows from basic resea.

Read full article arrow
News Thumbnail
8:00 AM | Thursday | Mar 26, 2026

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma

Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to aid in identifying patients with esophageal or gastroesophageal junction (GEJ) carcinoma who may be eligible for treatment with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy.
PD-L1 IHC 22C3 pharmDx, Code SK006, is the only FDA-approved companion diagnostic indica.

Read full article arrow
News Thumbnail
8:00 AM | Thursday | Mar 19, 2026

Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026

Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it will feature its latest advances in precision oncology and digital pathology workflows at the 2026 United States and Canadian Academy of Pathology (USCAP) Annual Meeting, taking place March 21-26 in San Antonio, Texas. Agilent will highlight expanded biomarker testing capabilities, continued progress in digital pathology adoption, and the evolving role of the Dako Omnis family of instruments as a founda.

Read full article arrow
News Thumbnail
8:00 AM | Wednesday | Mar 11, 2026

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company's expanding capabilities across Canada and the United States. Agilent Advanced Therapeutics brings together the strengths of BIOVECTRA in Canada and Nucleic Acid Solutions in Colorado to deliver a full suite of premium, scalable and customizable manufacturing so.

Read full article arrow
News Thumbnail
3:05 AM | Monday | Mar 9, 2026

Excellere Partners and GHO Capital Sell Biocare Medical to Agilent Technologies

GlobeNewsWire

Denver, CO and London, UK, 9 March 2026: Excellere Partners (“Excellere”), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, GHO Capital Partners LLP (“GHO”), a specialist investor in global healthcare, and Biocare Medical (“Biocare”), a global leader of immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) solutions, today announce that Biocare has entered into an agreement to be acquired by Agilent Technologies (“Agilent”, NYSE:A), a prominent player in life sciences, diagnostics, and applied chemical markets.

Read full article arrow
News Thumbnail